Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder

Completed · Not applicable

Conditions studied: Heart Septal Defects, Ventricular

In brief

The objective is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children.

Key facts

Study ID
NCT00583791
Run by
Abbott Medical Devices
People needed
91
Starts
2000-07-01
Expected to finish
2009-11-01
Last updated by the study team
2019-06-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.